Summer Electricity Costs Set to Surge as Heat Waves and Rising Rates Collide VIAVI Solutions Unveils CyberFlood CF1000 400G Security Test Platform Targeting HighSpeed Network Security Validation Federal Backing Triggers IonQ Stock Rally Short Squeeze Dynamics May Amplify Gains Market Recap 10 Key Factors Shaping Stock Trading on Wednesday Tesla Surpasses Profit Expectations Despite Revenue Miss as Auto Margins Improve Adani Powers 24 Stake Acquisition Drives JP Power Ventures Shares to Upper Circuit Hits 9Month High Universal Display OLED Q1 2026 Earnings EPS Misses by a Wide Margin Stock Slips 1 KROS Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Amid Pipeline Progress ZM Q1 2026 Earnings Strong EPS Beat Amid Revenue Discrepancy Stock Dips AZZ Inc Q1 2026 Earnings Strong Earnings Beat Amid Steady Operational Performance XP Q1 2026 Earnings EPS Miss and Stock Decline Signal Headwinds COYA Q1 2026 Earnings NarrowerThanExpected Loss Despite No Recognized Revenue First Western Financial MYFW Holds Steady Near Support Amid Low Volatility Integrated Media Technology IMTE Shows Resilience with 365 Gain Key Support and Resistance Levels in Focus Blackrock MuniYield Pennsylvania Quality Fund MPA Edges Higher Amid Steady Muni Bond Demand Waste Connections WCN Dips 121 as Resistance Holds Support Levels in Focus Cloudflare NET Holds Above Support After Recent Uptick Key Levels in Focus MainStreet Bancshares Depositary Shares MNSBP Edges Higher Amid Narrow Trading Range Brandywine Realty Trust BDN Holds Near 300 as Bulls Test Resistance Zone Meridian Holdings MRDN Inches Higher as It Approaches Key Resistance JFB Construction Holdings JFB Gains 318 as Shares Test Resistance Near 580 Highview Merger Corp Holds Steady at 1012 Amid Minimal Movement TriSalus Life Sciences TLSI Falls Over 5 as Stock Tests Key Support Near 310 Qualcomm Faces Persistent Short Seller Pressure as AI Pivot Becomes Critical for Bulls ALEC Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Neurodegenerative Pipeline Replimune Group REPL Slides 644 as Biotech Shares Face Renewed Pressure